366 related articles for article (PubMed ID: 7508119)
1. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington M; Grosmaire LS; Nonoyama S; Fischer SH; Hollenbaugh D; Ledbetter JA; Noelle RJ; Aruffo A; Ochs HD
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1099-103. PubMed ID: 7508119
[TBL] [Abstract][Full Text] [Related]
2. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
[TBL] [Abstract][Full Text] [Related]
3. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
4. [Reconstitution of immunoglobulin production in patients with variable immunodeficiency syndrome (CVI) by the CD40 system and IL-10].
Zielen S; Sehrt P; Rahmig J; Hofmann D; Brière F; Meuer SC
Immun Infekt; 1994 Feb; 22(1):24-5. PubMed ID: 7523284
[TBL] [Abstract][Full Text] [Related]
5. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
Ochs HD; Hollenbaugh D; Aruffo A
Semin Immunol; 1994 Oct; 6(5):337-41. PubMed ID: 7532462
[TBL] [Abstract][Full Text] [Related]
6. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
[TBL] [Abstract][Full Text] [Related]
7. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10.
Eisenstein EM; Chua K; Strober W
J Immunol; 1994 Jun; 152(12):5957-68. PubMed ID: 7515919
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.
Bajorath J; Chalupny NJ; Marken JS; Siadak AW; Skonier J; Gordon M; Hollenbaugh D; Noelle RJ; Ochs HD; Aruffo A
Biochemistry; 1995 Feb; 34(6):1833-44. PubMed ID: 7531493
[TBL] [Abstract][Full Text] [Related]
9. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.
Hollenbaugh D; Grosmaire LS; Kullas CD; Chalupny NJ; Braesch-Andersen S; Noelle RJ; Stamenkovic I; Ledbetter JA; Aruffo A
EMBO J; 1992 Dec; 11(12):4313-21. PubMed ID: 1385114
[TBL] [Abstract][Full Text] [Related]
10. Diminished expression of CD40 ligand by activated neonatal T cells.
Nonoyama S; Penix LA; Edwards CP; Lewis DB; Ito S; Aruffo A; Wilson CB; Ochs HD
J Clin Invest; 1995 Jan; 95(1):66-75. PubMed ID: 7814647
[TBL] [Abstract][Full Text] [Related]
11. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
12. Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation.
Eisenstein EM; Jaffe JS; Strober W
J Clin Immunol; 1993 Jul; 13(4):247-58. PubMed ID: 7901231
[TBL] [Abstract][Full Text] [Related]
13. B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation.
Saxon A; Sidell N; Zhang K
Cell Immunol; 1992 Oct; 144(1):169-81. PubMed ID: 1382864
[TBL] [Abstract][Full Text] [Related]
14. Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients.
Denz A; Eibel H; Illges H; Kienzle G; Schlesier M; Peter HH
Eur J Immunol; 2000 Apr; 30(4):1069-77. PubMed ID: 10760795
[TBL] [Abstract][Full Text] [Related]
15. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan C; Shi Y; Laman JD; Datta SK
J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
[TBL] [Abstract][Full Text] [Related]
16. Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis.
Bajorath J; Marken JS; Chalupny NJ; Spoon TL; Siadak AW; Gordon M; Noelle RJ; Hollenbaugh D; Aruffo A
Biochemistry; 1995 Aug; 34(31):9884-92. PubMed ID: 7543281
[TBL] [Abstract][Full Text] [Related]
17. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
18. Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4.
Nonoyama S; Farrington ML; Ochs HD
Clin Immunol Immunopathol; 1994 Sep; 72(3):373-9. PubMed ID: 7520376
[TBL] [Abstract][Full Text] [Related]
19. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency.
Fischer MB; Hauber I; Vogel E; Wolf HM; Mannhalter JW; Eibl MM
J Allergy Clin Immunol; 1993 Aug; 92(2):340-52. PubMed ID: 8349943
[TBL] [Abstract][Full Text] [Related]
20. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.
Nonoyama S; Farrington M; Ishida H; Howard M; Ochs HD
J Clin Invest; 1993 Sep; 92(3):1282-7. PubMed ID: 7690775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
